Dr Fiona Marshall

Fiona is VP at MSD where she is Head of Neuroscience Discovery and Head of the new Discovery Research Centre in London which is focused on research into diseases of ageing. Previously Fiona was Chief scientific officer at SoseiHeptares. Fiona was a founder of Heptares Therapeutics a highly successful UK Biotech company focussed on structure- based drug design. Fiona is most well known for her work in the field of G protein-coupled receptors. Whilst at GSK her team was responsible for the identification of the heterodimerization of the GABAB receptor, and the cloning of the RAMP/CGRP receptors, the HCA2 receptor and the free fatty acid receptors FFA2 and FFA3. Whilst at Heptares her team solved the X-ray structures of over 15 different GPCRs including the first structures of Class B and Class C receptors. Fiona won the 2012 WISE Women of Outstanding Achievement for Innovation and Entrepreneurship and the 2015 RSC Malcolm Campbell Award for chemistry. She is a Fellow of the Academy of Medical Sciences, Honorary Fellow of the British Pharmacological Society and Honorary Fellow of the Royal Society of Chemistry.